ライフサイエンスコーパス: be considered for

1 tients exhibited tumor avidity sufficient to be considered for (177)Lu-PSMA-617 PRRT.

2 owed that solid organ transplantation should be considered for 5-year childhood cancer survivors with

3 Finally, insights gained from the model are considered for a Goubau line with a rectangular cond

4 VEGF) treatment among patients who typically are considered for a therapy switch.

5 f mortality, all patients with an SRM should be considered for a biopsy when the results may alter ma

6 ted metabolites of polar contaminants should be considered for a comprehensive risk assessment in the

7 th common and low-frequency variants need to be considered for a comprehensive understanding of the g

8 for generating lightning on Jupiter need to be considered for a full understanding of the planet's a

9 ed consensus statements offer predictions to be considered for a personalized medicine approach in tr

10 It may also be considered for a wider range of coronaviruses, includ

11 rom the tyranny of tin" in radical processes was considered for a long time an unavoidable issue.

12 Here, the value of the binding affinity was considered for a single binding site and adjusted by

13 (PVCs) or VT and tachycardiomyopathy should be considered for ablation before ICD implantation becau

14 the prepared biocomposite chitosan films may be considered for active food packaging applications.

15 ng MAT into primary care settings that could be considered for adaptation across diverse health care

16 ing for screening for genetic HLH and should be considered for addition to current HLH criteria.

17 what logical axioms and new cell types could be considered for addition to the Cell Ontology.

18 sitive Q value on Scheimpflug imaging should be considered for additional power at the intraocular le

19 ting IL1beta-NFKB/CREB-Wnt signalling should be considered for adjuvant therapy to prevent breast can

20 oral immunotherapy is a treatment option to be considered for adults with food allergy who were not

21 tment costs, ex-factory prices (euro , 2019) were considered for aflibercept, ranibizumab and bevaciz

22 Total gastrectomy should be considered for all CDH1 mutation carriers because of

23 KPD should be considered for all living donor/recipient pairs becau

24 ing and testing with a multigene panel could be considered for all patients with early-onset CRC.

25 testing with multigene cancer panels should be considered for all young patients with CRC.

26 naloxone 8 mg or saline placebo if lung were being considered for allocation but exhibited hypoxemia

27 development stage, and harvest stage should be considered for alternative uses of end-products with

28 ts with risk factors for redo surgery should be considered for an open surgery in a high-volume cente

29 re available, of which 5,777 results (99.3%) were considered for analysis, including data from 3,095

30 Three datasets were considered for analysis, involving a total 59 482 o

31 Sixteen loci were considered for analysis.

32 ility in such materials is crucial when they are considered for application as filters in CWs.

33 ible reduced graphene oxide (rGO) sheets are being considered for applications in portable electrical

34 Increasingly, zeolites are being considered for applications under milder aqueous c

35 SiC is considered for applications in advanced nuclear syste

36 at the effects of ASOs on transcription must be considered for appropriate experimental and therapeut

37 domized data, left ventricular unloading may be considered for appropriately selected patients underg

38 thought to be therapeutically inefficient to be considered for ATT.

39 5 mammographic microcalcifications, but can be considered for BI-RADS 4 mammographic microcalcificat

40 newly diagnosed BC and BRCA1/2 mutations may be considered for breast-conserving therapy (BCT), with

41 Morbidly obese patients should be considered for BS before atrial fibrillation ablation

42 family other than the Solanaceae, and could be considered for canker control.

43 Dexrazoxane should be considered for cardioprotection during frontline trea

44 Radiotherapy can be considered for cases with nerve or lymph node involve

45 oproteins including their abundances need to be considered for cell classification rather than a sing

46 Novel approaches using bevacizumab should be considered for children with NF2.

47 Once daily, low-dose ferrous sulfate should be considered for children with nutritional iron-deficie

48 Near-infrared reflectance and G-FAF should be considered for classification of dot SDDs, and confoc

49 n currently recommended approaches and could be considered for clinical case finding of patients with

50 The test could be considered for clinical implementation after further

51 ents whose tumors harbor this program should be considered for clinical trials testing rational agent

52 conclude that PAMs and NAMs of mGluRs should be considered for clinical trials.

53 n is a highly frequent phenomena that should be considered for comprehensive feature annotation.

54 sation of this motion is feasible and should be considered for coronary PET imaging.

55 Careful patient selection should be considered for CRT-D implantation in patients with no

56 ng an important role for PET in triaging men being considered for curative SRT.

57 or with equivocal CT for advanced stage, who were considered for curative-intent first-line therapy.

58 ples of the cellular cold response that must be considered for current and future applications involv

59 Symptomatic female subjects should be considered for current and upcoming gene replacement

60 45 patients met this MCCC criterion and were considered for data analysis.

61 most potent CD73 inhibitors reported and may be considered for development as parenteral drugs.

62 overall effectiveness of therapy and should be considered for development of more potent drugs.

63 ssful clearance of FMDV infection and should be considered for development of next-generation vaccine

64 s may shed light on whether MOR SNPs need to be considered for devising effective therapeutic interve

65 Peculiarities of eigenvalue behaviour are considered for different permittivity ranges of loss

66 studies, namely non-treatment and treatment, are considered for discovering biomarker genes.

67 boelastography-directed selective use should be considered for documented HF.

68 influence decisions were listed as notes to be considered for each scenario.

69 An average of 3.5 +/- 1.5 GPM frames were considered for each patient, resulting in an averag

70 ultiple landfill diversion and budget levels were considered for each scenario.

71 Empiric treatment should be considered for ELBW infants delivered vaginally who h

72 r atmospheric organic chemicals which should be considered for emissions monitoring and impact assess

73 This information allows more options to be considered for empiric therapy, at least for some pat

74 Available standards were considered for endorsement.

75 ity Oncology Dispensing Association (NCODA), were considered for endorsement.

76 sponse and safety after 12 weeks in order to be considered for enrolment into the extension study.

77 mposition in pediatric infection that should be considered for eradication efforts.

78 of the spike are critical factors that must be considered for evaluating the emergence potential and

79 approaches related to the RAS pathway might be considered, for example, inhalational administration

80 s of studies - non-treatment and treatment - are considered for experiment.

81 and that patients with TP53 mutations should be considered for experimental frontline trials explorin

82 idence and relief of regional lithology must be considered for explaining biogeography, evolution, lo

83 The approach that we outline can be considered for external validations of criminal justi

84 esults, we propose that recycled jute should be considered for fabrication of high-performance flexib

85 ICE 3: Genetic testing and counseling should be considered for familial pancreas cancer relatives who

86 d control trials and two diagnostic studies) were considered for full text qualitative and quantitati

87 two secondary statistical analysis studies) were considered for full text qualitative and quantitati

88 ing their main core, and, in perspective can be considered for functional integrations optical-induce

89 admission to a KMC ward or corner and could be considered for further assessment.

90 tile function in vitro and hence, they might be considered for further cell-based therapy study on wo

91 We suggest our methodology could be considered for further developments in theoretical tr

92 those with normal renal function, and should be considered for further investigation and treatment.

93 erapy to reduce bone destruction that should be considered for further testing and development toward

94 r programmatic impact evaluations and should be considered for future analyses.

95 This effect needs to be considered for future applications requiring high-qua

96 e evidence is needed, eating frequency could be considered for future chrono-nutritional recommendati

97 This formulation should be considered for future efficacy trials.

98 people living with HIV abusing opioids could be considered for future HIV cure research efforts.

99 V for the detection of metastases and should be considered for future oncologic imaging clinical tria

100 arget these provirus-harboring cells need to be considered for future therapies aimed toward HIV-1 cu

101 e antigenic type or immunotype that needs to be considered for future vaccine strategies against huma

102 lthy lifestyle during early pregnancy should be considered for GDM prevention.

103 Further molecular testing should be considered for gliomas with discordant neuroimaging a

104 Therefore, (68)Ga-PSMA PET/CT may be considered for guidance of bone biopsies in both clin

105 Large cohort studies were considered for harms of antidepressant use only.

106 Routine anti-HDV testing should be considered for HBsAg carriers.

107 To be considered for HCT, patients must have HIV infection

108 duction of S Typhi conjugate vaccines should be considered for high-incidence settings, such as those

109 utine post-discharge pharmacoprophylaxis can be considered for high-risk patients (ie, VTE risk >0.4%

110 ial to be automated and parallelized, it can be considered for high-throughput screening in metabolic

111 al symptoms only and skin prick test < 8 mm) are considered for home-based milk reintroduction (HMR).

112 MSM with normal aLBC/HR-HPV infection should be considered for HRA.

113 Pending validation, this technology should be considered for human use.

114 nt are the management approaches that should be considered for hypogonadism and hypoadrenalism.

115 ed multiple myeloma in patients who were not being considered for immediate autologous stem-cell tran

116 d before vitamin D(3) supplementation should be considered for implementation in HIV care and treatme

117 dies, as potential functional overlap has to be considered for in vitro and in vivo studies.

118 preliminary checklist of reporting items to be considered for inclusion in the guideline.

119 ted with TIPS between May 2011 and June 2016 were considered for inclusion.

120 Patients who underwent surgery/biopsy were considered for inclusion.

121 meta-analyses, reviews) in English or French were considered for inclusion.

122 ain injury requiring invasive ICP monitoring were considered for inclusion.

123 ntraocular lens in a private practice clinic were considered for inclusion.

124 , to September 30, 2014, in Ontario, Canada, were considered for inclusion.

125 Thus, assessment of these variants should be considered for incorporation into precision medicine

126 ination, suggesting Ad26 booster doses could be considered for individuals at risk of Ebola infection

127 tion strategies for the RBD immunogen should be considered for inducing strongly neutralizing antibod

128 This immunisation approach should be considered for induction of preventive antibodies in

129 arket-leading HCV viral load test and should be considered for instances where rapid near-to-patient

130 T is more convenient for patients and should be considered for intermediate-risk prostate cancer.

131 ages with and without attenuation correction were considered for interpretation.

132 Under care of these teams, patients should be considered for intestinal transplantation in the even

133 developing dnDSA, so dnDSA positivity should be considered for IS withdrawal eligibility; during IS m

134 easing diversity of engineered nanomaterials being considered for large-scale use, this high-throughp

135 celerometry was feasibly deployed and should be considered for larger-scale national surveys.

136 nts with a heterozygous A1AT mutation should be considered for living-liver donation.

137 Variables with p values of less than 0.1 were considered for logistic regression analysis to iden

138 Variables with p values of less than 0.1 were considered for logistic regression analysis which i

139 (5) comorbidities in NAFLD/NASH patients who are considered for LT need to be assessed in the pretran

140 Use of fibrinogen concentrate may be considered for management of bleeding in patients wit

141 in protein aggregation, making RNA, that has been considered for many years a 'silent presence' or th

142 rth Vallis has always been a prime target to be considered for Mars rover missions due to its rich mi

143 Ivermectin is being considered for mass drug administration for malari

144 nant individuals, 3'UTR-Delta10-LAV may also be considered for maternal vaccination.

145 Only four articles were considered for meta-analysis, as the other two were

146 high quality evidence and only four articles were considered for meta-analysis, as these provided log

147 USBR should be considered for metastatic SB-NETs.

148 pression and function suggests that it could be considered for mitochondrial disease therapy and/or t

149 ures such as HGD and multifocal cysts should be considered for more intensive surveillance and repres

150 tumors that measure >20 mm at imaging should be considered for neoadjuvant treatment regardless of re

151 accination, and a booster vaccination should be considered for nonendemic vaccinees before travel to

152 It is of special importance in group D eyes being considered for nonsystemic treatment, such as prim

153 New treatment options need to be considered for now-discernible HRDetect-intermediate

154 alternate local treatment strategies should be considered for older, luminal B, and HER2 driven BC p

155 quence-specific, the resulting effect should be considered for oligonucleotide-based therapeutics in

156 e data in cystic fibrosis registries, should be considered for ongoing surveillance and study.

157 bility, unemployment, and low income) should be considered for optimal assessment, management, and pr

158 It should be considered for other routine tasks performed on corne

159 ed, and the bioderivatization strategy could be considered for other similar chemicals as well.

160 eloped to manage Alzheimer's disease and now being considered for other therapeutic interventions, ar

161 ycin distribution for trachoma continues and is considered for other indications, ongoing monitoring

162 ith proliferative diabetic retinopathy (PDR) be considered for pan-retinal photocoagulation (PRP) tre

163 to a dilemma regarding which patients should be considered for parathyroid surgery.

164 Most patients with pHPT should be considered for parathyroidectomy.

165 HIV-infected patients requiring HCT may also be considered for participation in trials evaluating the

166 IMPORTANCE Monocloncal antibodies (MAbs) are being considered for passive immunotherapy of HIV-1 infe

167 Thrombolysis should be considered for patients at low risk for bleeding who

168 restaging generally is not suggested but can be considered for patients at risk for metastases or who

169 d cultures are low-yield, blood cultures can be considered for patients at risk of adverse events if

170 This intervention may be considered for patients exposed to potential epilepto

171 Prostate MRI should be considered for patients in high-risk populations prio

172 s not proven, so targeted therapy should not be considered for patients in this category which should

173 Neoadjuvant imatinib therapy should be considered for patients requiring extensive surgery,

174 theless, treatment with anti-CD20 Abs should be considered for patients requiring transfusion with a

175 These findings should be considered for patients taking biotin supplements bef

176 l-extracorporeal membrane oxygenation should be considered for patients with acute decompensated hear

177 Early surgical intervention may be considered for patients with additional signs.

178 The results suggest that lithium should be considered for patients with bipolar disorder with su

179 rporeal cardiopulmonary resuscitation should be considered for patients with cardiac diagnoses and in

180 Statins may be considered for patients with elevated 10-year risk (>

181 knowledge, the longest yet reported and can be considered for patients with good PS.

182 ernative unboosted integrase regimens should be considered for patients with high risk of harm from D

183 Radioisotopic lobectomy should be considered for patients with low- to intermediate-ris

184 New treatments that reduce tongue fat should be considered for patients with OSA.

185 Temporary placement of a single FCSEMS may be considered for patients with PCBS not involving the m

186 ernative unboosted integrase regimens should be considered for patients with risk of harm from DDIs.

187 idence that bariatric procedures should also be considered for patients with type 2 diabetes and a bo

188 These observations should be considered for planning future studies.

189 Therefore, if GSS testing is being considered for point-of-care diagnosis of N. gonor

190 Actions to be considered for preventing childhood obesity include t

191 HIV outbreaks and other lessons learned can be considered for preventing, detecting, and responding

192 blockade of the renin-angiotensin system may be considered for primary AF prevention in hypertensive

193 s and proposes a process by which others may be considered for primary care preventive recommendation

194 participation or health resource use should be considered for primary outcome assessment in future t

195 The findings suggest that caspofungin may be considered for prophylaxis against invasive fungal di

196 rmed, and therapeutic anticoagulation should be considered for prophylaxis, as all coronavirus diseas

197 pecific targeting of SERCA2b by Tg analogues is considered for prostate cancer therapy, the inhibitio

198 as input variables and twelve quality grades were considered for quality of fish as output variables

199 orrection for more accurate T1 values should be considered for quantitative dynamic contrast-enhanced

200 Reasons are considered for radiology practices on both sides of

201 Placebo comparisons are increasingly being considered for randomised trials assessing the eff

202 s; therefore, enhancing their quality should be considered for regenerative therapies.

203 RPLND should be considered for relapsed patients, especially those wi

204 y as recommended rescue treatments and could be considered for rescue treatment for Plasmodium falcip

205 Implications are considered for research in fields such as mechanisti

206 and consequently which brain regions should be considered for resection.

207 insecticides with different modes of action is considered for resistance management.

208 BPE should be considered for risk prediction models for women under

209 ce-based therapy for hypertension should not be considered for routine treatment.

210 ostdischarge malaria chemoprophylaxis should be considered for SA children living in malaria endemic

211 east one dose of chemoprophylaxis or placebo were considered for safety, those receiving PfSPZ Challe

212 Facility-based HIV self-testing should be considered for scale-up in settings with a high unmet

213 Persons without prior screening should be considered for screening up to age 85, depending on a

214 shown to refine risk stratification and can be considered for select men to improve management decis

215 olates, and species-level identification can be considered for selected noninvasive isolates to impro

216 w the major therapeutic strategies that have been considered for sepsis and might be amenable to repu

217 ensitivity limits of novel diagnostic assays being considered for simplified HCV treatment monitoring

218 with advanced renal dysfunction and HCC may be considered for SLK.

219 , particularly if treatment de-escalation is being considered for small or node negative tumors.

220 pecific assays are very promising and should be considered for smartphone-based analysis.

221 ecision aid in all patients with T1 melanoma being considered for SNB.

222 Only patients with treated cancer are considered for SOT but the benefits of transplantati

223 nterventions are therefore viable options to be considered for SPAF.

224 al conventional imaging results and who were being considered for SRT.

225 the SSR in specific situations and it should be considered for SSR computation.

226 ction of modular proteins and therefore must be considered for stabilizing protein-based pharmaceutic

227 t increased atherosclerotic CVD risk and may be considered for statins.

228 or survival driven by excess toxicity, could be considered for strategies focused on minimizing toxic

229 undergoing adrenal metastasectomy and should be considered for subjects with isolated adrenal metasta

230 the PET tracer of choice when PET-CT imaging is considered for subsequent treatment management decisi

231 The addition of selenium should be considered for supplements containing antioxidant mix

232 with carotid stenosis enter surveillance or are considered for surgery on the basis of disease sever

233 do not wish to retain their fertility should be considered for surgical management.

234 ups of survivors, particularly males, should be considered for surveillance of cerebrovascular risk f

235 In these patients, catheter ablation is considered for symptom management or to treat tachyca

236 ts carried the greatest risk of AF and could be considered for targeted monitoring.

237 ting requires an understanding of who should be considered for testing and when it should be performe

238 ncipal stress directions of the stress state are considered (for the crystallographic directions obse

239 hy revealed an IgE Ab binding site that will be considered for the design of hypoallergens for immuno

240 This has to be considered for the design of tumour cell directed nan

241 lterations induced by AAV-CRISPR that should be considered for the development of AAV-CRISPR as a the

242 targeting chloride regulation in neurons may be considered for the development of new antiepileptic d

243 These compounds should, therefore, be considered for the development of novel antiplatelet

244 ism of this worldwide-used drug, which shall be considered for the development of safer therapeutic s

245 etabolic bioactivation uncovered here should be considered for the evaluation and design of clinical

246 Their connectivity network needs to be considered for the full understanding of biological p

247 Dulaglutide could be considered for the management of glycaemic control in

248 nd as approved drugs in wide human use could be considered for the novel indication of human optic ne

249 indicate that HDL-C raising strategies could be considered for the prevention of ischaemic small vess

250 It may be considered for the prognostic stratification of metas

251 ility and low cost, we suggest that CQ could be considered for the treatment and prophylaxis of ZIKV.

252 These data suggest that metronidazole may be considered for the treatment of initial mild CDI amon

253 suggest that NET-targeting approaches could be considered for the treatment of uncontrolled tissue-d

254 th locally available standard of care should be considered for the underlying nAMD.

255 estriction regimens, including fasting, have been considered for the prevention and treatment of cert

256 s in the management of patients requiring or being considered for the following clinical therapies: 1

257 of aspirin among persons in whom aspirin is being considered for the primary prevention of CVD.

258 n people worldwide, a wide spectrum of drugs is considered for the treatment in the concept of repurp

259 An awake uptake period was considered for the anesthesia scans.

260 ns from volunteers, and chemometric analysis was considered for the development of models for predict

261 -reflection X-ray fluorescence method (TXRF) were considered for the analysis of tea.

262 anticoagulation or DAPT before the procedure were considered for the final analysis.

263 Twelve implants were considered for the statistical analysis (n = 12).

264 y Hospital from September 2013 to March 2016 were considered for the study.

265 and the adaptive immune system, which should be considered for therapeutic approaches of autoimmune d

266 tective and detrimental species, which might be considered for therapeutic targeting.

267 Alternative surveillance strategies, could be considered for these individuals.

268 Co-doped ZnO (ZnCoO) has been considered for these applications, but the origin o

269 SLN biopsy may be considered for thin melanomas that are T1b (0.8 to 1.

270 mmendations made about which patients should be considered for this intervention.

271 ronchoscopy and TBLB for various indications were considered for this study.

272 s they are diagnosed, and monotherapy should be considered for those in the low-mortality-score strat

273 e, asymptomatic HIV-infected adults, and may be considered for those with symptomatic HIV infection i

274 of circadian rhythm on neuroprotection must be considered for translational studies in stroke and ce

275 Organs from donors with ITP may be considered for transplantation, but livers should be

276 ibuting to poor post-HLTx outcomes may still be considered for transplantation, potentially with less

277 -risk kidneys subjected to long CIT may have been considered for transplantation.

278 Additional targets are considered for treating tardive dyskinesia and negat

279 hibition of phospholipase A2 (PLA2) has long been considered for treating various diseases associated

280 ich is widely available and inexpensive, can be considered for treatment of bacterial keratitis when

281 patients, suggesting that lenvatinib should be considered for treatment of patients of any age with

282 Methylnaltrexone should be considered for treatment of refractory OIC in cancer

283 iological, and microbiologic criteria-should be considered for treatment.

284 e-related macular degeneration (AMD) who are being considered for treatment with antioxidants and zin

285 ly increases the number of patients that may be considered for treatments targeting HR deficiency.

286 cancers with FGFR pathway alterations should be considered for trials using combinations of ER, CDK4/

287 etinoblastoma Staging System [IRSS] stage I) were considered for upfront enucleation.

288 myosins, in addition to parvalbumins, should be considered for urgently needed improved fish allergy

289 The PALICC PARDS framework should be considered for use in future epidemiological and ther

290 on a definition of clinical cure that could be considered for use in future HABP/VABP clinical trial

291 es in a high-transmission setting and should be considered for use in malaria in pregnancy interventi

292 male patients with breast cancer and should be considered for use in newly diagnosed patients, parti

293 e (LPS) O antigen (OAg) of F. tularensis has been considered for use in a glycoconjugate vaccine, but

294 Strategies to elicit similar responses may be considered for vaccine designs to achieve optimal pro

295 de), a group IV transition metal carbide, is being considered for various high temperature applicatio

296 areas, with cardiac modelling and simulation being considered for virtual testing of pharmacological

297 suggest that higher daptomycin doses need to be considered for VRE-BSI treatment.

298 icacy data for the leading candidate vaccine being considered for widespread use.

299 Conclusion Screening breast MRI should be considered for women with a personal history of breas

300 ls, suggesting that these parameters need to be considered for ZIKV vaccine design.